Insiders Johnson & Johnson

Equities

JNJ

US4781601046

Market Closed - Nyse Other stock markets 01:30:02 09/05/2024 am IST			5-day change	1st Jan Change
149 ^USD	+0.15%		-1.48%	-4.97%

07/05	Tylenol maker Kenvue beats quarterly profit estimates, to cut 4% jobs	RE
06/05	J&J: encouraging results in prostate cancer	CF

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Recursion Pharmaceuticals Names Najat Khan Chief R&D Officer	17/04	MT
Clearside Biomedical Names Victor Chong Chief Medical Officer	18/03	MT
Johnson & Johnson Insider Sold Shares Worth $1,441,765, According to a Recent SEC Filing	14/03	MT
LivaNova Names Vladimir Makatsaria as Chief Executive	05/02	MT
Joseph Wolk, CFO of J&J: End of patent for its flagship drug	23/01	MT
Top Stories at Midday: Boeing Declines After FAA Grounding; Twilio Names New CEO; Johnson & Johnson May Pay $700 Million Talc Probe Settlement; Moderna Rises on $6.7 Billion COVID-19 Vaccine Sales	08/01	MT
Johnson & Johnson Names Eugene Woods as Board Member	01/12	DJ
Johnson & Johnson Appoints Eugene A. Woods to its Board of Directors	01/12	CI
Johnson & Johnson Announces Executive Changes	24/23/24	CI
Middle East Worries Weaken Exchange-Traded Funds, Equity Futures Premarket Tuesday	17/23/17	MT
Biomea Fusion Names Juan Pablo Frias as Chief Medical Officer, Steve Morris to Become Chief Development Officer	31/23/31	MT
US government names first 10 drugs for Medicare price negotiation	29/23/29	RE
US to name first 10 drugs for Medicare price negotiation	29/23/29	RE
Top Stories at Midday: Yellow Calls it Quits; JNJ Unit Loses Second Bid at Bankruptcy; JB Hunt Buys Nikola Trucks, Walmart Raises Flipkart Stake	31/23/31	MT
Insider Sell: Johnson & Johnson	28/23/28	MT
Insider Sell: Johnson & Johnson	28/23/28	MT
INTERVIEW - Joseph Wolk, Johnson & Johnson: inflation law may hamper innovation	20/23/20	MT
Idorsia's Commercial Chief to Step Down	30/23/30	MT
Nyxoah Appoints Chief Commercial Officer	11/23/11	MT
Johnson & Johnson Announces the Retirement of Ian E. L. Davis as Director	03/23/03	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Joseph Wolk, CFO of J&J: End of patent for its flagship drug

January 23, 2024 at 11:00 pm IST